Aboukameel A - Search Results

1

Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Azmi AS, Philip PA, Aboukameel A, Wang Z, Banerjee S, Zafar SF, Goustin AS, Almhanna K, Yang D, Sarkar FH, Mohammad RM. Azmi AS, et al. Among authors: aboukameel a. Curr Cancer Drug Targets. 2010 May;10(3):319-31. doi: 10.2174/156800910791190229. Curr Cancer Drug Targets. 2010. PMID: 20370686 Free PMC article.

2

Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.

Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A. Mohammad R, et al. Among authors: aboukameel a. Clin Cancer Res. 2002 Apr;8(4):1277-83. Clin Cancer Res. 2002. PMID: 11948143

3

Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.

Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR, Al-Katib AM. Nabha SM, et al. Among authors: aboukameel a. Clin Cancer Res. 2002 Aug;8(8):2735-41. Clin Cancer Res. 2002. PMID: 12171907

4

Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient.

Mohammad RM, Aboukameel A, Nabha S, Ibrahim D, Al-Katib A. Mohammad RM, et al. Among authors: aboukameel a. J Drug Target. 2002 Aug;10(5):405-10. doi: 10.1080/1061186021000001850. J Drug Target. 2002. PMID: 12442811

5

The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.

Al-Katib AM, Mensah-Osman E, Aboukameel A, Mohammad R. Al-Katib AM, et al. Among authors: aboukameel a. Semin Oncol. 2003 Apr;30(2):313-7. doi: 10.1053/sonc.2003.50043. Semin Oncol. 2003. PMID: 12720160

6

Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.

Marciniak DJ, Moragoda L, Mohammad RM, Yu Y, Nagothu KK, Aboukameel A, Sarkar FH, Adsay VN, Rishi AK, Majumdar AP. Marciniak DJ, et al. Among authors: aboukameel a. Gastroenterology. 2003 May;124(5):1337-47. doi: 10.1016/s0016-5085(03)00264-6. Gastroenterology. 2003. PMID: 12730874

7

Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.

Mohammad RM, Al-Katib A, Aboukameel A, Doerge DR, Sarkar F, Kucuk O. Mohammad RM, et al. Among authors: aboukameel a. Mol Cancer Ther. 2003 Dec;2(12):1361-8. Mol Cancer Ther. 2003. PMID: 14707277

8

Levi E, Mohammad R, Kodali U, Marciniak D, Reddy S, Aboukameel A, Sarkar FH, Kucuk O, Rishi AK, Majumdar AP. Levi E, et al. Among authors: aboukameel a. Anticancer Res. 2004 Sep-Oct;24(5A):2885-91. Anticancer Res. 2004. PMID: 15517892 Free article.

9

Structure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folates.

Liu M, Ge Y, Cabelof DC, Aboukameel A, Heydari AR, Mohammad R, Matherly LH. Liu M, et al. Among authors: aboukameel a. J Biol Chem. 2005 Feb 18;280(7):5588-97. doi: 10.1074/jbc.M412662200. Epub 2004 Dec 3. J Biol Chem. 2005. PMID: 15579899 Free article.

10

Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma.

Mohammad RM, Wang S, Aboukameel A, Chen B, Wu X, Chen J, Al-Katib A. Mohammad RM, et al. Among authors: aboukameel a. Mol Cancer Ther. 2005 Jan;4(1):13-21. Mol Cancer Ther. 2005. PMID: 15657349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters